Scientists identify RIOK1 enzyme as new target for cancer therapy

[News]

Dr. Florian Weinberg, from Prof. Dr. Tilman Brummer's research group at the Institute of Molecular Medicine and Cell Research of the University of Freiburg, joined forces with scientists from the Departments of Clinical Pathology and Medicine I of the University Medical Centre Freiburg and the Kinghorn Cancer Centre/Garvan Insitute in Australia in an international team that has identified a new target for cancer therapy.

More... (http://www.news-medical.net/news/20170505/Scientists-identify-RIOK1-enzyme-as-new-target-for-cancer-therapy.aspx)